share_log
Breakings ·  Nov 15 20:00
Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for Pbgene-Hbv for Treatment of Chronic Hepatitis B
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment